logo

Pfizer Inc. (PFE)



Trade PFE now with
  Date
  Headline
7/23/2019 8:10:34 AM Syapse Enters Into Strategic Collaboration With Pfizer To Advance Cancer Outcomes Research
7/22/2019 12:41:39 AM InvaGen Receives Final Approval For Generic Version Of Pfizer's Pregabalin Capsules
7/3/2019 4:14:29 AM GSK: ViiV Healthcare Receives EU Marketing Authorisation For Dovato
7/2/2019 8:20:12 AM Calithera Biosciences Begins Phase 1/2 Trial Of Telaglenastat In Combination With Pfizer’s CDK4/6 Inhibitor Palbociclib
7/1/2019 8:03:11 AM Pfizer Announces Top-line Results From Phase 4 Study CrisADe CARE 1
6/28/2019 10:40:09 AM Pfizer To Present Initial Phase 1b Data On PF-06939926, Investigational Gene Therapy To Potentially Treat DMD
6/28/2019 7:34:59 AM Pfizer Receives FDA Approval For Its Oncology Biosimilar, ZIRABEV
6/27/2019 4:31:39 PM Pfizer Declares Quarterly Dividend Of $0.36/share, Payable Sept. 3/record Aug. 2
6/27/2019 4:31:21 PM Pfizer Elects Scott Gottlieb To Board Of Directors
6/27/2019 4:30:38 PM Pfizer Inc. (PFE) Declares $ 0.36 Dividend for Q3 19, Record Date 8/2/2019
6/17/2019 6:57:30 AM Pfizer To Acquire Array For $48/Shr For Total Enterprise Value Of $11.4 Bln
6/12/2019 8:07:40 AM Pfizer Announces Positive Results From XELJANZ XR ORAL Shift Study